| Literature DB >> 27790371 |
Soichi Oka1, Hiroki Matsumiya1, Shuichi Shinohara1, Taiji Kuwata1, Masaru Takenaka1, Yasuhiro Chikaishi1, Ayako Hirai1, Naoko Imanishi1, Koji Kuroda1, Sohsuke Yamada2, Hidetaka Uramoto1, Eiichiro Nakamura3, Fumihiro Tanaka1.
Abstract
BACKGROUND: Surgery for lung cancer invading the spine remains challenging associated with high morbidity and mortality. However, recent advances in surgical techniques as well as in perioperative care may improve outcomes of lung cancer surgery with vertebrectomy. We describe our surgical approach and assess the outcome lung cancer invading the spine.Entities:
Keywords: CBDCA, carboplatin; CDDP, cisplatin; CT, computed tomography; Lung cancer; MRI, magnetic resonance imaging; NSCLC, non-small cell lung cancer; PET, positron emission tomography; Spine; Vertebrectomy
Year: 2016 PMID: 27790371 PMCID: PMC5072144 DOI: 10.1016/j.amsu.2016.10.002
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Fig. 1Type of vertebrectomy for lung cancer invading the spine.
Characteristics of patients undergoing resection for lung cancer invading the spine.
| # | Age/Sex | Induction therapy | Type of pulmonary resection | Type of vertebrectomy | Number of resected levels | Operation time (hour) | Complication | Histology | Pathological tumor stage | Completeness of resection | Adjuvant treatment | Status/Recurrence | Follow-up (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 35/M | None | Lobectomy | Total | 1(Th3) | 17.5 | None | Pleomorphic carcinoma | pT4N0M0 | R0 | Chemotherapy | Alive/None | 62 |
| 2 | 67/M | None | Lobectomy | Transverse | 3(Th3-5) | 9.8 | Postoperative bleeding | Adenocarcinoma | pT3N0M0 | R0 | Chemotherapy | Alive/None | 51 |
| 3 | 69/F | None | Lobectomy | Transverse | 4(Th3-6) | 10.9 | Air-leakage | Small cell carcinoma | pT3N0M0 | R0 | None | Alive/Brain metastasis | 49 |
| 4 | 74/M | None | Lobectomy | Transverse | 2(Th2-3) | 13.6 | Postoperative bleeding | Adenocarcinoma | pT4N0M0 | R0 | None | Alive/None | 33 |
| 5 | 46/M | None | Lobectomy | Half | 3(Th3-5) | 19.0 | Both recurrent nerve paralysis | Adenocarcinoma | pT4N0M0 | R0 | None | Alive/Lt adrenal metastasis | 30 |
| 6 | 62/M | Chemoradiation | Lobectomy | Total | 1(Th2) | 33.3 | Both recurrent nerve paralysis | Squamous cell carcinoma | pT4N0M0 | R0 | None | Dead/Local recurrence | 15 |
| 7 | 59/M | Chemoradiation | Lobectomy | Half | 2(Th3-4) | 18.6 | Both recurrent nerve paralysis, Empyema | Squamous cell carcinoma | pT4N0M0 | R0 | None | Dead/Local recurrence | 17 |
| 8 | 77/F | None | Lobectomy | Transverse | 2(Th7-8) | 14.3 | None | Squamous cell carcinoma | pT4N0M0 | R0 | None | Alive/None | 14 |
Fig. 2Overall survival of patients undergoing resection for lung cancer invading the spine.